Department of Urology, Michigan Medicine, Ann Arbor, MI, USA.
Department of Urology, Mayo Clinic, Rochester, MN, USA.
Nat Commun. 2024 May 21;15(1):4341. doi: 10.1038/s41467-024-48629-y.
Localized prostate cancer is frequently composed of multiple spatially distinct tumors with significant inter- and intra-tumoral molecular heterogeneity. This genomic diversity gives rise to many competing clones that may drive the biological trajectory of the disease. Previous large-scale sequencing efforts have focused on the evolutionary process in metastatic prostate cancer, revealing a potential clonal progression to castration resistance. However, the clonal origin of synchronous lymph node (LN) metastases in primary disease is still unknown. Here, we perform multi-region, targeted next generation sequencing and construct phylogenetic trees in men with prostate cancer with synchronous LN metastasis to better define the pathologic and molecular features of primary disease most likely to spread to the LNs. Collectively, we demonstrate that a combination of histopathologic and molecular factors, including tumor grade, presence of extra-prostatic extension, cellular morphology, and oncogenic genomic alterations are associated with synchronous LN metastasis.
局部前列腺癌通常由多个具有显著的肿瘤内和肿瘤间分子异质性的空间上不同的肿瘤组成。这种基因组多样性产生了许多可能驱动疾病生物学轨迹的竞争克隆。先前的大规模测序工作主要集中在转移性前列腺癌的进化过程上,揭示了向去势抵抗性进展的潜在克隆进化。然而,原发疾病中同步淋巴结(LN)转移的克隆起源仍然未知。在这里,我们对患有同步 LN 转移的前列腺癌患者进行了多区域、靶向的下一代测序,并构建了系统发育树,以更好地定义最有可能转移到 LN 的原发疾病的病理和分子特征。总的来说,我们证明了包括肿瘤分级、存在前列腺外延伸、细胞形态和致癌基因组改变在内的组织病理学和分子因素的组合与同步 LN 转移相关。